New glasses film aims to stop nearsightedness before it starts

NCT ID NCT07401511

Not yet recruiting Prevention Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special optical film called S.T.O.P®KIT that attaches to eyeglasses. The goal is to slow down the growth of the eye in children aged 6 to 10 with mild farsightedness, which may help prevent nearsightedness later. 180 children will be split into two groups: one gets the special glasses, the other gets regular check-ups. The study will measure changes in eye length and vision over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dynamic Spatiotemporal Optical Film (S.T.O.P®KIT) attached to eyeglasses
What this could lead to: If it works, this could provide a simple, non-invasive way to prevent nearsightedness in children with mild farsightedness.
What could go wrong: This is an early-stage study with only 180 children, and it's not yet recruiting. The effect may be small or not work at all, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDREN HYPEROPIA

Contacts and locations

Locations

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200080, China
The First Affiliated Hospital of Zhengzhou University

Zhenzhou, Henan, 450052, China
Yuhuangding Hospital of Yantai

Yantai, Shandong, 264000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.